CDC Says Fewer Suffer After Lyme Disease. Doesn’t Say, If Treated Early. “They prefer to minimize Lyme disease; they prefer to make it seem like it doesn’t exist.”
By Mary Beth Pfeiffer
F or at least five years, the U.S. Centers for Disease Control and Prevention has officially stated that 10 to 20 percent of patients treated for Lyme disease — some 30,000 to 60,000 of 300,000 infected yearly — “will have lingering symptoms of fatigue, pain, or joint and muscle aches,” even after supposedly curative antibiotic treatment.
But quietly, without peer review or formal announcement, the agency has decided that the actual percentage is much smaller — half or a quarter as much. The decision was made, officials told me, based on a study that showed less than 5 percent of Lyme patients exhibit ongoing symptoms after treatment.
Consequently, the CDC’s web site now states that “a small percentage” of patients will have lingering symptoms of what is called Post-treatment Lyme Disease Syndrome or PTLDS. Other studies have found higher shares of patients suffering after treatment, particularly when diagnosis is delayed. The study cited by the CDC was of patients treated early and who exhibited symptoms on average 15 years later.
The agency’s pronouncement involves the most contentious issue in the debate over Lyme disease: why — and how many — people have problems involving pain, mobility, and mental and physical functioning even after taking single-course antibiotics recommended by the Infectious Diseases Society of America, or IDSA… Join or login below to continue reading.
You must be a LymeDisease.org member to access this content.
If you are already a member, log in below. Otherwise, become a member today to access the full content of this article and the full library of Lyme Times articles.
* Physician Directory Memberships do not have access to the Lyme Times.